“For most people with urinary tract infections (UTIs), a short course of antibiotics is the go-to treatment. But for complicated urinary tract infections — severe bacterial illnesses that are resistant to different forms of antibiotics — this may not be adequate.

Now people with difficult-to-treat UTIs have a new medication option: The FDA has approved an antibiotic pill called Utebzi (tebipenem pivoxil).

Developed by GlaxoSmithKline (GSK) in collaboration with Spero Therapeutics, Utebzi is an oral form of an antibiotic class called carbapenems, a standard treatment for complicated UTIs. Before Utebzi, people with complicated UTIs could only get carbapenems intravenously.”

From Everyday Health.